BSX logo

Boston Scientific (BSX) Cash From Financing

Annual CFF

$5.00 M
+$553.00 M+100.91%

31 December 2023

BSX Cash From Financing Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly CFF

$7.00 M
-$17.00 M-70.83%

30 September 2024

BSX Quarterly CFF Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

TTM CFF

$1.61 B
-$9.00 M-0.55%

30 September 2024

BSX TTM CFF Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

BSX Cash From Financing Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+100.9%-56.3%+10000.0%
3 y3 years-98.3%+16.7%+278.3%
5 y5 years-99.7%-99.5%-60.8%

BSX Cash From Financing High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3 years-98.3%+100.9%-99.5%+102.0%-1.7%+278.3%
5 y5 years-99.8%+100.9%-99.5%+100.8%-60.8%+239.1%
alltimeall time-99.9%+100.3%-99.9%+100.7%-80.9%+179.6%

Boston Scientific Cash From Financing History

DateAnnualQuarterlyTTM
Sept 2024
-
$7.00 M(-70.8%)
$1.61 B(-0.6%)
June 2024
-
$24.00 M(-98.5%)
$1.62 B(-1.2%)
Mar 2024
-
$1.57 B(>+9900.0%)
$1.64 B(>+9900.0%)
Dec 2023
$5.00 M(-100.9%)
$15.00 M(-6.3%)
$5.00 M(-155.6%)
Sept 2023
-
$16.00 M(-62.8%)
-$9.00 M(-96.0%)
June 2023
-
$43.00 M(-162.3%)
-$224.00 M(-63.3%)
Mar 2023
-
-$69.00 M(-7000.0%)
-$611.00 M(+11.5%)
Dec 2022
-$548.00 M(+476.8%)
$1.00 M(-100.5%)
-$548.00 M(-1.6%)
Sept 2022
-
-$199.00 M(-42.2%)
-$557.00 M(+58.2%)
June 2022
-
-$344.00 M(+5633.3%)
-$352.00 M(+5766.7%)
Mar 2022
-
-$6.00 M(-25.0%)
-$6.00 M(-93.7%)
Dec 2021
-$95.00 M(-132.4%)
-$8.00 M(-233.3%)
-$95.00 M(-89.5%)
Sept 2021
-
$6.00 M(+200.0%)
-$906.00 M(-22.0%)
June 2021
-
$2.00 M(-102.1%)
-$1.16 B(+1901.7%)
Mar 2021
-
-$95.00 M(-88.4%)
-$58.00 M(-119.8%)
Dec 2020
$293.00 M(-90.1%)
-$819.00 M(+228.9%)
$293.00 M(-24.5%)
Sept 2020
-
-$249.00 M(-122.5%)
$388.00 M(-80.1%)
June 2020
-
$1.10 B(+331.6%)
$1.95 B(+77.0%)
Mar 2020
-
$256.00 M(-135.4%)
$1.10 B(-62.9%)
Dec 2019
$2.97 B(+107.6%)
-$724.00 M(-155.1%)
$2.97 B(-27.9%)
Sept 2019
-
$1.31 B(+413.3%)
$4.12 B(+39.3%)
June 2019
-
$256.00 M(-88.0%)
$2.96 B(-13.7%)
Mar 2019
-
$2.13 B(+400.5%)
$3.43 B(+139.5%)
Dec 2018
$1.43 B(+1201.8%)
$425.00 M(+181.5%)
$1.43 B(+52.5%)
Sept 2018
-
$151.00 M(-79.2%)
$939.00 M(+44.7%)
June 2018
-
$726.00 M(+458.5%)
$649.00 M(+154.5%)
Mar 2018
-
$130.00 M(-291.2%)
$255.00 M(+131.8%)
Dec 2017
$110.00 M(-153.4%)
-$68.00 M(-51.1%)
$110.00 M(-46.6%)
Sept 2017
-
-$139.00 M(-141.9%)
$206.00 M(-45.6%)
June 2017
-
$332.00 M(-2313.3%)
$379.00 M(-322.9%)
Mar 2017
-
-$15.00 M(-153.6%)
-$170.00 M(-17.5%)
Dec 2016
-$206.00 M(-116.1%)
$28.00 M(-17.6%)
-$206.00 M(-56.3%)
Sept 2016
-
$34.00 M(-115.7%)
-$471.00 M(-284.0%)
June 2016
-
-$217.00 M(+325.5%)
$256.00 M(-80.6%)
Mar 2016
-
-$51.00 M(-78.5%)
$1.32 B(+3.4%)
Dec 2015
$1.28 B(-950.7%)
-$237.00 M(-131.1%)
$1.28 B(-14.9%)
Sept 2015
-
$761.00 M(-10.0%)
$1.50 B(+98.3%)
June 2015
-
$846.00 M(-1000.0%)
$756.00 M(-1000.0%)
Mar 2015
-
-$94.00 M(+571.4%)
-$84.00 M(-44.0%)
Dec 2014
-$150.00 M(-76.0%)
-$14.00 M(-177.8%)
-$150.00 M(-62.6%)
Sept 2014
-
$18.00 M(+200.0%)
-$401.00 M(-28.0%)
June 2014
-
$6.00 M(-103.8%)
-$557.00 M(-16.9%)
Mar 2014
-
-$160.00 M(-39.6%)
-$670.00 M(+7.4%)
Dec 2013
-$624.00 M(-18.3%)
-$265.00 M(+92.0%)
-$624.00 M(+0.5%)
Sept 2013
-
-$138.00 M(+29.0%)
-$621.00 M(-14.0%)
June 2013
-
-$107.00 M(-6.1%)
-$722.00 M(-3.2%)
Mar 2013
-
-$114.00 M(-56.5%)
-$746.00 M(-2.4%)
Dec 2012
-$764.00 M(-55.8%)
-$262.00 M(+9.6%)
-$764.00 M(-5.7%)
Sept 2012
-
-$239.00 M(+82.4%)
-$810.00 M(+8.0%)
June 2012
-
-$131.00 M(-0.8%)
-$750.00 M(-45.2%)
Mar 2012
-
-$132.00 M(-57.1%)
-$1.37 B(-20.8%)
Dec 2011
-$1.73 B(+240.2%)
-$308.00 M(+72.1%)
-$1.73 B(-14.8%)
Sept 2011
-
-$179.00 M(-76.1%)
-$2.03 B(+10.5%)
June 2011
-
-$750.00 M(+52.7%)
-$1.84 B(+81.2%)
Mar 2011
-
-$491.00 M(-19.4%)
-$1.01 B(+99.4%)
Dec 2010
-$508.00 M(-38.0%)
-$609.00 M(-4450.0%)
-$508.00 M(+1853.8%)
Sept 2010
-
$14.00 M(-80.8%)
-$26.00 M(-89.4%)
June 2010
-
$73.00 M(+421.4%)
-$246.00 M(-22.6%)
Mar 2010
-
$14.00 M(-111.0%)
-$318.00 M(-61.2%)
Dec 2009
-$820.00 M(-39.3%)
-$127.00 M(-38.3%)
-$820.00 M(+18.8%)
Sept 2009
-
-$206.00 M(<-9900.0%)
-$690.00 M(-29.4%)
June 2009
-
$1.00 M(-100.2%)
-$977.00 M(-21.1%)
Mar 2009
-
-$488.00 M(<-9900.0%)
-$1.24 B(-8.2%)
Dec 2008
-$1.35 B
$3.00 M(-100.6%)
-$1.35 B(-4.2%)
Sept 2008
-
-$493.00 M(+88.9%)
-$1.41 B(-13.8%)
June 2008
-
-$261.00 M(-56.4%)
-$1.63 B(+24.7%)
DateAnnualQuarterlyTTM
Mar 2008
-
-$599.00 M(+969.6%)
-$1.31 B(+92.6%)
Dec 2007
-$680.00 M(-108.1%)
-$56.00 M(-92.2%)
-$680.00 M(+11.5%)
Sept 2007
-
-$718.00 M(-1239.7%)
-$610.00 M(-558.6%)
June 2007
-
$63.00 M(+103.2%)
$133.00 M(-98.3%)
Mar 2007
-
$31.00 M(+121.4%)
$7.79 B(-7.7%)
Dec 2006
$8.44 B(-984.6%)
$14.00 M(-44.0%)
$8.44 B(+6.2%)
Sept 2006
-
$25.00 M(-99.7%)
$7.95 B(-5.1%)
June 2006
-
$7.72 B(+1040.8%)
$8.37 B(+1082.6%)
Mar 2006
-
$677.00 M(-242.2%)
$708.00 M(-174.2%)
Dec 2005
-$954.00 M(-317.3%)
-$476.00 M(-206.0%)
-$954.00 M(-5.2%)
Sept 2005
-
$449.00 M(+674.1%)
-$1.01 B(-32.3%)
June 2005
-
$58.00 M(-105.9%)
-$1.49 B(+149.6%)
Mar 2005
-
-$985.00 M(+86.6%)
-$595.00 M(-235.5%)
Dec 2004
$439.00 M(-9.9%)
-$528.00 M(+1660.0%)
$439.00 M(-61.3%)
Sept 2004
-
-$30.00 M(-103.2%)
$1.13 B(-6.4%)
June 2004
-
$948.00 M(+1834.7%)
$1.21 B(+255.1%)
Mar 2004
-
$49.00 M(-70.5%)
$341.00 M(-30.0%)
Dec 2003
$487.00 M(-378.3%)
$166.00 M(+245.8%)
$487.00 M(+109.9%)
Sept 2003
-
$48.00 M(-38.5%)
$232.00 M(+95.0%)
June 2003
-
$78.00 M(-60.0%)
$119.00 M(-440.0%)
Mar 2003
-
$195.00 M(-319.1%)
-$35.00 M(-80.0%)
Dec 2002
-$175.00 M(-140.0%)
-$89.00 M(+36.9%)
-$175.00 M(+230.2%)
Sept 2002
-
-$65.00 M(-14.5%)
-$53.00 M(-152.5%)
June 2002
-
-$76.00 M(-238.2%)
$101.00 M(-75.0%)
Mar 2002
-
$55.00 M(+66.7%)
$404.00 M(-7.6%)
Dec 2001
$437.00 M(-168.5%)
$33.00 M(-62.9%)
$437.00 M(+55.0%)
Sept 2001
-
$89.00 M(-60.8%)
$282.00 M(+1384.2%)
June 2001
-
$227.00 M(+158.0%)
$19.00 M(-104.6%)
Mar 2001
-
$88.00 M(-172.1%)
-$409.00 M(-35.9%)
Dec 2000
-$638.00 M(+7.6%)
-$122.00 M(-29.9%)
-$638.00 M(-6.9%)
Sept 2000
-
-$174.00 M(-13.4%)
-$685.00 M(-12.6%)
June 2000
-
-$201.00 M(+42.6%)
-$784.00 M(+17.9%)
Mar 2000
-
-$141.00 M(-16.6%)
-$665.00 M(+12.1%)
Dec 1999
-$593.00 M(-130.5%)
-$169.00 M(-38.1%)
-$593.00 M(-15.3%)
Sept 1999
-
-$273.00 M(+232.9%)
-$700.00 M(-142.3%)
June 1999
-
-$82.00 M(+18.8%)
$1.66 B(-6.8%)
Mar 1999
-
-$69.00 M(-75.0%)
$1.78 B(-8.5%)
Dec 1998
$1.94 B(+1099.4%)
-$276.00 M(-113.3%)
$1.94 B(-14.6%)
Sept 1998
-
$2.08 B(+5241.0%)
$2.28 B(+818.2%)
June 1998
-
$39.00 M(-59.8%)
$247.80 M(-5.5%)
Mar 1998
-
$97.00 M(+72.3%)
$262.10 M(+61.8%)
Dec 1997
$162.00 M(-18.7%)
$56.30 M(+1.4%)
$162.00 M(+17.1%)
Sept 1997
-
$55.50 M(+4.1%)
$138.40 M(+115.6%)
June 1997
-
$53.30 M(-1819.4%)
$64.20 M(-62.7%)
Mar 1997
-
-$3.10 M(-109.5%)
$172.30 M(-13.5%)
Dec 1996
$199.30 M(+1913.1%)
$32.70 M(-274.9%)
$199.30 M(+4.9%)
Sept 1996
-
-$18.70 M(-111.6%)
$190.00 M(-1.6%)
June 1996
-
$161.40 M(+575.3%)
$193.00 M(+430.2%)
Mar 1996
-
$23.90 M(+2.1%)
$36.40 M(+267.7%)
Dec 1995
$9.90 M(+98.0%)
$23.40 M(-249.0%)
$9.90 M(-193.4%)
Sept 1995
-
-$15.70 M(-427.1%)
-$10.60 M(-207.1%)
June 1995
-
$4.80 M(-284.6%)
$9.90 M(+67.8%)
Mar 1995
-
-$2.60 M(-189.7%)
$5.90 M(+18.0%)
Dec 1994
$5.00 M(-109.8%)
$2.90 M(-39.6%)
$5.00 M(-256.3%)
Sept 1994
-
$4.80 M(+500.0%)
-$3.20 M(-87.7%)
June 1994
-
$800.00 K(-122.9%)
-$26.10 M(-51.9%)
Mar 1994
-
-$3.50 M(-34.0%)
-$54.30 M(+6.5%)
Dec 1993
-$51.00 M(-152.1%)
-$5.30 M(-70.7%)
-$51.00 M(+11.1%)
Sept 1993
-
-$18.10 M(-33.9%)
-$45.90 M(+63.9%)
June 1993
-
-$27.40 M(>+9900.0%)
-$28.00 M(-126.4%)
Mar 1993
-
-$200.00 K(0.0%)
$106.10 M(+8.4%)
Dec 1992
$97.90 M(-841.7%)
-$200.00 K(0.0%)
$97.90 M(-0.2%)
Sept 1992
-
-$200.00 K(-100.2%)
$98.10 M(-0.2%)
June 1992
-
$106.70 M(-1370.2%)
$98.30 M(-1270.2%)
Mar 1992
-
-$8.40 M
-$8.40 M
Dec 1991
-$13.20 M
-
-

FAQ

  • What is Boston Scientific annual cash flow from financing activities?
  • What is the all time high annual CFF for Boston Scientific?
  • What is Boston Scientific annual CFF year-on-year change?
  • What is Boston Scientific quarterly cash flow from financing activities?
  • What is the all time high quarterly CFF for Boston Scientific?
  • What is Boston Scientific quarterly CFF year-on-year change?
  • What is Boston Scientific TTM cash flow from financing activities?
  • What is the all time high TTM CFF for Boston Scientific?
  • What is Boston Scientific TTM CFF year-on-year change?

What is Boston Scientific annual cash flow from financing activities?

The current annual CFF of BSX is $5.00 M

What is the all time high annual CFF for Boston Scientific?

Boston Scientific all-time high annual cash flow from financing activities is $8.44 B

What is Boston Scientific annual CFF year-on-year change?

Over the past year, BSX annual cash flow from financing activities has changed by +$553.00 M (+100.91%)

What is Boston Scientific quarterly cash flow from financing activities?

The current quarterly CFF of BSX is $7.00 M

What is the all time high quarterly CFF for Boston Scientific?

Boston Scientific all-time high quarterly cash flow from financing activities is $7.72 B

What is Boston Scientific quarterly CFF year-on-year change?

Over the past year, BSX quarterly cash flow from financing activities has changed by -$9.00 M (-56.25%)

What is Boston Scientific TTM cash flow from financing activities?

The current TTM CFF of BSX is $1.61 B

What is the all time high TTM CFF for Boston Scientific?

Boston Scientific all-time high TTM cash flow from financing activities is $8.44 B

What is Boston Scientific TTM CFF year-on-year change?

Over the past year, BSX TTM cash flow from financing activities has changed by +$1.62 B (+18044.44%)